Drug Safety Research Unit

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. University of Verona意大利6
2. University of Groningen荷兰5
3. Université de Bordeaux法国5
4. University Medical Center Utrecht荷兰3
5. University of Florida美国3
6. Netherlands Pharmacovigilance Centre Lareb荷兰3
7. Utrecht University荷兰3
8. Leibniz Institute for Prevention Research and Epidemiology - BIPS德国2

按月发文

逐年被引

最新文献

1. 1
   Toward a Framework for Case Identification in Pharmacovigilance: Not All Reports are Created EqualDrug Safety20260
2. 2
   Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of ExcellenceDrug Safety20261
3. 3
   Current Challenges in Monitoring the Safety and Utilisation of the Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): A UK PerspectiveDrug Safety20260
4. 4
   A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future ImprovementsDrug Safety20261
5. 5
   Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus GroupDrug Safety20260
6. 6
   Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceDrug Safety202539
7. 7
   Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory ActionPharmacoepidemiology and Drug Safety20241
8. 8
   What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance StudyDrug Safety202410
9. 9
   Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023Drug Safety20231
10. 10
    Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical TrialsDrug Safety202314

高被引文献

1. 1
   Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk AssessmentDrug Safety202069
2. 2
   Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk AssessmentDrug Safety202067
3. 3
   Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceDrug Safety202539
4. 4
   The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO ProjectDrug Safety201529
5. 5
   Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First DoseDrug Safety202328
6. 6
   Specialist Cohort Event Monitoring Studies: A New Study Method for Risk Management in PharmacovigilanceDrug Safety201526
7. 7
   Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in EnglandDrug Safety201619
8. 8
   The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UKDrug Safety201915
9. 9
   How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 VaccineDrug Safety202014
10. 10
    Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical TrialsDrug Safety202314

主要发表期刊

研究主题